Clinical
New clinical trial registered for Bortezomib
Related compound: BortezomibView source →
A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adult Patients With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And Lymphomas (NCT07513129) registered on ClinicalTrials.gov. Phase: phase 1. Status: not yet recruiting.